Terms: = Lymphoma AND Ki-67 AND Clinical Outcome
40 results:
1. clinical outcome of Mantle Cell lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).
Scheubeck G; Jiang L; Hermine O; Kluin-Nelemans HC; Schmidt C; Unterhalt M; Rosenwald A; Klapper W; Evangelista A; Ladetto M; Jerkeman M; Ferrero S; Dreyling M; Hoster E
Leukemia; 2023 Sep; 37(9):1887-1894. PubMed ID: 37495776
[TBL] [Abstract] [Full Text] [Related]
2. Blastoid and Pleomorphic Mantle Cell lymphoma Demonstrate Distinct Clinicopathologic and Genetic Features.
Khanlari M; Mo H; Kim DH; Sakhdari A; Young KH; Jain P; Wang M; Li S; Kanagal-Shamanna R; Miranda RN; Vega F; Medeiros LJ; Ok CY
Am J Surg Pathol; 2023 Aug; 47(8):849-858. PubMed ID: 37288826
[TBL] [Abstract] [Full Text] [Related]
3. clinical significance of plasma PD-L1
Xu P; Liu J; Chen H; Shang L; Wang F; Zhu Y; Guo Y; Li F; Yan F; Xie X; Li L; Gu W; Lin Y
Ann Hematol; 2023 Sep; 102(9):2435-2444. PubMed ID: 37162517
[TBL] [Abstract] [Full Text] [Related]
4. Proliferative Tumor-Infiltrating Lymphocytes' Abundance within the Microenvironment Impacts clinical outcome in Cutaneous B-Cell lymphomas.
Menguy S; Prochazkova-Carlotti M; Azzi-Martin L; Ferté T; Bresson-Bepoldin L; Rey C; Vergier B; Merlio JP; Beylot-Barry M; Pham-Ledard A
J Invest Dermatol; 2023 Jan; 143(1):124-133.e3. PubMed ID: 35970476
[TBL] [Abstract] [Full Text] [Related]
5. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.
Zhou H; Xu-Monette ZY; Xiao L; Strati P; Hagemeister FB; He Y; Chen H; Li Y; Manyam GC; Li Y; Montes-Moreno S; Piris MA; Young KH
Blood Cancer J; 2020 May; 10(5):49. PubMed ID: 32366834
[TBL] [Abstract] [Full Text] [Related]
7. Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi.
Fedoriw Y; Selitsky S; Montgomery ND; Kendall SM; Richards KL; Du W; Tomoka T; Mulenga M; Parker JS; Dave SS; Gopal S
Mod Pathol; 2020 Aug; 33(8):1482-1491. PubMed ID: 32080349
[TBL] [Abstract] [Full Text] [Related]
8. T-cell leukemia/lymphoma-1A predicts the clinical outcome for patients with stage II/III colorectal cancer.
Li H; Yan X; Liu L; Huang L; Yin M; Pan C; Zhang P; Qin H
Biomed Pharmacother; 2017 Apr; 88():924-930. PubMed ID: 28178623
[TBL] [Abstract] [Full Text] [Related]
9. Anaplastic lymphoma kinase expression and gene alterations in glioblastoma: correlations with clinical outcome.
Karagkounis G; Stranjalis G; Argyrakos T; Pantelaion V; Mastoris K; Rontogianni D; Komaitis S; Kalamatianos T; Sakas D; Tiniakos D
J Clin Pathol; 2017 Jul; 70(7):593-599. PubMed ID: 27993946
[TBL] [Abstract] [Full Text] [Related]
10. High ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy.
Song MK; Chung JS; Lee JJ; Yang DH; Kim IS; Shin DH; Shin HJ
Int J Hematol; 2015 Feb; 101(2):140-7. PubMed ID: 25504496
[TBL] [Abstract] [Full Text] [Related]
11. Role of CD204-positive tumor-associated macrophages in adult T-cell leukemia/lymphoma.
Saito Y; Komohara Y; Niino D; Horlad H; Ohnishi K; Takeya H; Kawaguchi H; Shimizu H; Ohshima K; Takeya M
J Clin Exp Hematop; 2014; 54(1):59-65. PubMed ID: 24942947
[TBL] [Abstract] [Full Text] [Related]
12. [Clinicopathological characteristics and prognostic analysis of 92 cases with primary gastrointestinal diffuse large B-cell lymphoma].
Feng J; Wan W; Wan W; Wang J; Jing H; Wang J; Zhao W; Liu Y; Ke X
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):288-94. PubMed ID: 24759013
[TBL] [Abstract] [Full Text] [Related]
13. Association of quantitative assessment of the intrafollicular proliferation index with outcome in follicular lymphoma.
Kedmi M; Hedvat CV; Maragulia J; Zhang Z; Zelenetz AD
Br J Haematol; 2014 Mar; 164(5):646-52. PubMed ID: 24303881
[TBL] [Abstract] [Full Text] [Related]
14. Intranodular clusters of activated cells with T follicular helper phenotype in nodular lymphocyte predominant Hodgkin lymphoma: a pilot study of 32 cases from Finland.
Nathwani BN; Vornanen M; Winkelmann R; Kansal R; Doering C; Hartmann S; Hansmann ML
Hum Pathol; 2013 Sep; 44(9):1737-46. PubMed ID: 23684509
[TBL] [Abstract] [Full Text] [Related]
15. Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2).
Changchien YC; Tátrai P; Papp G; Sápi J; Fónyad L; Szendrői M; Pápai Z; Sápi Z
J Transl Med; 2012 Oct; 10():216. PubMed ID: 23110793
[TBL] [Abstract] [Full Text] [Related]
16. Primary breast diffuse large B-cell lymphoma shows an activated B-cell-like phenotype.
Li D; Deng J; He H; Bu Y; Peng F; Tang X; Wang B; Lei Y; Zhang H; Xie P
Ann Diagn Pathol; 2012 Oct; 16(5):335-43. PubMed ID: 22569408
[TBL] [Abstract] [Full Text] [Related]
17. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
Kodet R; Mrhalová M; Stejskalová E; Kabícková E
Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
[TBL] [Abstract] [Full Text] [Related]
18. Primary testicular diffuse large B-cell lymphoma shows an activated B-cell-like phenotype.
Li D; Xie P; Mi C
Pathol Res Pract; 2010 Sep; 206(9):611-5. PubMed ID: 20627604
[TBL] [Abstract] [Full Text] [Related]
19. Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome.
Gualco G; Weiss LM; Harrington WJ; Bacchi CE
Am J Surg Pathol; 2009 Dec; 33(12):1815-22. PubMed ID: 19816150
[TBL] [Abstract] [Full Text] [Related]
20. Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034.
Chadburn A; Chiu A; Lee JY; Chen X; Hyjek E; Banham AH; Noy A; Kaplan LD; Sparano JA; Bhatia K; Cesarman E
J Clin Oncol; 2009 Oct; 27(30):5039-48. PubMed ID: 19752343
[TBL] [Abstract] [Full Text] [Related]
[Next]
